Upregulated MiRNAs on the and Binding Seedless Regions in High-Risk HPV-Associated Penile Cancer
Overview
Authors
Affiliations
Cancer development by the human papillomavirus (HPV) infection can occur through the canonical HPV/p53/RB1 pathway mediated by the E2/E6/E7 viral oncoproteins. During the transformation process, HPV inserts its genetic material into host Integration Sites (IS), affecting coding genes and miRNAs. In penile cancer (PeCa) there is limited data on the miRNAs that regulate mRNA targets associated with HPV, such as the and genes. Considering the high frequency of HPV infection in PeCa patients in Northeast Brazil, global miRNA expression profiling was performed in high-risk HPV-associated PeCa that presented with and mRNA downregulated expression. The miRNA expression profile of 22 PeCa tissue samples and five non-tumor penile tissues showed 507 differentially expressed miRNAs: 494 downregulated and 13 upregulated (let-7a-5p, miR-130a-3p, miR-142-3p, miR-15b-5p miR-16-5p, miR-200c-3p, miR-205-5p, miR-21-5p, miR-223-3p, miR-22-3p, miR-25-3p, miR-31-5p and miR-93-5p), of which 11 were identified to be in HPV16-IS and targeting and genes. One hundred and thirty-one and 490 miRNA binding sites were observed for and , respectively, most of which were in seedless regions. These findings suggest that up-regulation of miRNA expression can directly repress and expression by their binding sites in the non-canonical seedless regions.
A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.
Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.
PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.
Cao J, Du L, Zhao X, Liu Z, Yuan J, Luo Y Genes Immun. 2024; 25(6):447-458.
PMID: 39242755 DOI: 10.1038/s41435-024-00295-2.
Zhong Y, Cao Y, Geng X, Yang S, Qian T, Liu C BMC Infect Dis. 2024; 24(1):490.
PMID: 38741041 PMC: 11089769. DOI: 10.1186/s12879-024-09375-0.
Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies.
Wei L, Huang K, Han H, Liu R Int J Mol Sci. 2023; 24(23).
PMID: 38069131 PMC: 10706305. DOI: 10.3390/ijms242316808.
Silva J, Deus A, Vale A, Azevedo-Santos A, Nogueira L, Laus A Am J Cancer Res. 2023; 13(11):5466-5481.
PMID: 38058800 PMC: 10695795.